Cryopreservation of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide at -80°C without rate-controlled freezing

Transfusion

Volumn 36, Issue 9, 1996, Pages 794-797

  Galmes A ^a   Besalduch, J ^a   Bargay, J ^a   Matamoros, N ^a   Duran M A ^a   Morey, M ^a   Alvarez, F ^a   Mascaro M ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; BREAST CANCER; CELL VIABILITY; CLINICAL ARTICLE; CRYOPRESERVATION; FEMALE; FREEZING; HEMATOPOIESIS; HUMAN; LYMPHOMA; MALE; MYELOMA;

EID: 0029820654     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36996420755.x     Document Type: Article

References (13)

1. Makino S, Harada M, Akashi K, et al. A simplified method for cryopreservation of peripheral blood stem cells at -80°C without rate-controlled freezing. Bone Marrow Transplant 1991;8:239-44.
2. Stiff PJ, Koester AR, Weidner MK, et al. Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing. Blood 1987;70:974-8.
3. Galmés A, Besalduch J, Bargay J, et al. A simplified method for cryopreservation of hematopoietic stem cells with -80°C mechanical freezer with dimethyl sulfoxide as the sole cryoprotectant. Leuk Lymphoma 1995;17:181-4.
4. Hernández-Navarro F, Ojeda E, Arrieta R, et al. Single-centre experience of peripheral blood stem cell transplantation using cryopreservation by immersion in a methanol bath. Bone Marrow Transplant 1995;16:71-7.
5. Philip T, Armitage JO, Spitzer G, et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or highgrade non-Hodgkin's lymphoma. N Engl J Med 1987;316:1493-8.
6. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulphan and cyclophosphamide regimen. Blood 1987;70:1382-8.
7. Eder JP, Elias A, Shea TC, et al. A phase III study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients. J Clin Oncol 1990;8:1239-45.
8. Rowley SD, Bensinger WI, Gooley TA, Buckner CD. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994;83:2731-6.
9. Langenmayer I, Weaver C, Buckner CD, et al. Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both. Bone Marrow Transplant 1995;15:241-6.
10. Davis JM, Rowley SD, Braine HG, et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990;75:781-6.
11. Kessinger A, Schmit-Pokorny K, Smith D, Armitage J. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant 1990:5(Suppl 1):25-7.
12. Douay L, Gorin NC, David R, et al. Study of granulocyte-macrophage progenitor (CFUc) preservation after slow freezing of bone marrow in the gas phase of liquid nitrogen. Exp Hematol 1982;10:360-6.
13. Rowley SD. Techniques of bone marrow and stem cell cryopreservation and storage. In: Sacher RA, AuBuchon JP, eds. Marrow transplantation: practical and technical aspects of stem cell reconstitution. Bethesda: American Association of Blood Banks, 1992:105-27.